Practice of Superselective Transarterial Infusion Therapy of High-dose Cisplatin with Concomitant Irradiation on Head and Neck Cancers; Focused on the Maxillary Cancer

Abstract

Superselective transarterial infusion therapy of high-dose cisplatin with concomitant irradiation is to infuse cisplatin to tumor feeding arteries directly via a catheter. Sodium thiosulfate which is a neutralizer of cisplatin facilitates this method performed. Malignant head and neck tumors are a good indication for this method. In particular, maxillary cancer is particularly suitable indication. In this article, we describe the practice and efficacy of this method in detail.